4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-21-000036
Chief Medical Officer sold 17,611 shares at an average $55.12 ($970,636)
- Chief Medical Officer acquired 17,611 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Bowden Christopher · Chief Medical Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-04-19 | Exercise or conversion : show line 1 in the form | +3,210 | $35.16 | $112,864 | 18,697 | D |
| 2021-04-19 | Sale : show line 2 in the form | −3,210 | $55.16 | $177,055 | 15,487 | D |
| 2021-04-20 | Exercise or conversion : show line 3 in the form | +12,513 | $35.16 | $439,957 | 28,000 | D |
| 2021-04-20 | Exercise or conversion : show line 4 in the form | +1,888 | $39.76 | $75,067 | 29,888 | D |
| 2021-04-20 | Sale : show line 5 in the form | −14,401 | $55.11 | $793,582 | 15,487 | D |
| Open-market sales · 17,611 sh · avg $55.12 · $970,636 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-04-19 | Exercise or conversion : show line 6 in the form Stock option (right to buy) | −3,210 | 12,513 | D |
| 2021-04-20 | Exercise or conversion : show line 7 in the form Stock option (right to buy) | −12,513 | 0 | D |
| 2021-04-20 | Exercise or conversion : show line 8 in the form Stock option (right to buy) | −1,888 | 43,332 | D |
Loading xslF345X03/wf-form4_161903949035322.xml…